Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/29/16 → 4/29/19 |
Funding
- ICON Clinical Research, LLC (Prot #D4190C00023 // Prot #D4190C00023)
- MedImmune, LLC (Prot #D4190C00023 // Prot #D4190C00023)
Prot #D4190C00023: A Phase 1b Study to Evaluate the Safety and Efficacy of MEDI4736 as Monotherapy and in Combination with Tremelimumab or AZD9150 in Subjects with Relapsed or Refractory Diffuse Large B-cell Lymphoma
- Pro, Barbara (PD/PI)
Project: Research project